Clinical Trial Update: Thiopurine Induced Pancreatitis in IBD Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial on thiopurine-induced pancreatitis in inflammatory bowel disease patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Pancreatitis

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Pancreatitis, Inflammatory Bowel Diseases | Phase 4 | Status: WITHDRAWN